Gene · 9002
Papers2,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic biomarkers for smoking cessation. | Addict Neurosci | 2023 | 37123087 | PubTator, text mining | PubMed |
| The Forms of the Lectin Tff2 Differ in the Murine Stomach and Pancreas: Indications for Different Molecular Functions. | Int J Mol Sci | 2023 | 37108221 | PubTator, text mining | PubMed |
| What can we learn from senescent platelets, their transcriptomes and proteomes? | Platelets | 2023 | 37070955 | PubTator, text mining | PubMed |
| Protease-activated receptors and glycoprotein VI cooperatively drive the platelet component in thromboelastography. | J Thromb Haemost | 2023 | 37068592 | PubTator, text mining | PubMed |
| The Regulation of Neutrophil Migration in Patients with Sepsis: The Complexity of the Molecular Mechanisms and Their Modulation in Sepsis and the Heterogeneity of Sepsis Patients. | Cells | 2023 | 37048076 | PubTator, text mining | PubMed |
| Novel Aspects Targeting Platelets in Atherosclerotic Cardiovascular Disease-A Translational Perspective. | Int J Mol Sci | 2023 | 37047253 | PubTator, text mining | PubMed |
| Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands. | Int J Mol Sci | 2023 | 37047169 | PubTator, text mining | PubMed |
| Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis. | Cancers (Basel) | 2023 | 37046617 | PubTator, text mining | PubMed |
| Low α-Thrombin/GPIbα Interaction Is a Potential Contributor to Platelet Hyper-reactivity in COVID-19 Patients. | Thromb Haemost | 2023 | 37044132 | PubTator, text mining | PubMed |
| Ontogenesis of functional platelet subpopulations from preterm and term neonates to adulthood: The PLINIUS study. | Blood Adv | 2023 | 37042931 | PubTator, text mining | PubMed |
| Amplification of protease-activated receptors signaling in sporadic cerebral cavernous malformation endothelial cells. | Biochim Biophys Acta Mol Cell Res | 2023 | 37030452 | PubTator, text mining | PubMed |
| Protease-activated receptors in kidney diseases: A comprehensive review of pathological roles, therapeutic outcomes and challenges. | Chem Biol Interact | 2023 | 37011708 | PubTator, text mining | PubMed |
| Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation. | Front Behav Neurosci | 2023 | 37009000 | PubTator, text mining | PubMed |
| Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies. | Thromb Res | 2023 | 37001283 | PubTator, text mining | PubMed |
| DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites. | Clin Epigenetics | 2023 | 36991458 | PubTator, text mining | PubMed |
| Biomarkers of Osteoarthritis-A Narrative Review on Causal Links with Metabolic Syndrome. | Life (Basel) | 2023 | 36983885 | PubTator, text mining | PubMed |
| Pruritogenic Mediators and New Antipruritic Drugs in Atopic Dermatitis. | J Clin Med | 2023 | 36983094 | PubTator, text mining | PubMed |
| ADP receptor P2Y12 is the capstone of the cross-talk between Ca2+ mobilization pathways dependent on Ca2+ ATPases sarcoplasmic/endoplasmic reticulum type 3 and type 2b in platelets. | Res Pract Thromb Haemost | 2023 | 36970741 | PubTator, text mining | PubMed |
| Targeting biased signaling by PAR1: function and molecular mechanism of parmodulins. | Blood | 2023 | 36952648 | PubTator, text mining | PubMed |
| Platelets in the tumor microenvironment and their biological effects on cancer hallmarks. | Front Oncol | 2023 | 36937386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9002/papers?page=10